SCHEMBL1485441

SCHEMBL1485441

CC(=O)NNC(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5606190 0.79
SCHEMBL21728783 0.77
SCHEMBL15795937 0.75
SCHEMBL542297 0.75 ALDH1A1 (0.37)
SCHEMBL542299 0.75 ALDH1A1 (0.37)
SCHEMBL23221248 0.75
SCHEMBL3058544 0.73
SCHEMBL23081624 0.73 MAOA (0.39)
SCHEMBL11926269 0.73 GAA (0.41)
SCHEMBL2423255 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 82 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2988597-B1 MACROLIDES AND METHODS OF THEIR PREPARATION AND USE HARVARD COLLEGE (US) 2022-06-08 EP disclosed
US-10712353-B2 Antibodies to olanzapine haptens and use thereof JANSSEN PHARMACEUTICA NV (BE) 2020-07-14 US disclosed
WO-2020068689-A1 TERPINOID DERIVATIVES AND USES THEREOF FRONTHERA U.S. PHARMACEUTICALS LLC (US) 2020-04-02 WO disclosed
EP-3082877-B1 CYTOTOXIC PEPTIDES AND CONJUGATES THEREOF NOVARTIS AG (CH) 2019-08-28 EP disclosed
WO-2019145245-A1 HERBICIDALLY ACTIVE 3-PHENYLISOXAZOLINE-5-CARBOXAMIDES OF CYCLOPENTENYL CARBOXYLIC ACID DERIVATIVES BAYER AKTIENGESELLSCHAFT (DE) 2019-08-01 WO disclosed
EP-2922575-B1 TRIOXACARCINS, TRIOXACARCIN-ANTIBODY CONJUGATES, AND USES THEREOF HARVARD COLLEGE (US) 2019-06-26 EP disclosed
EP-2688891-B1 BENZOXAZEPIN COMPOUNDS SELECTIVE FOR PI3K P110 DELTA AND METHODS OF USE HOFFMANN LA ROCHE (CH) 2017-11-15 EP disclosed
EP-2688891-B1 BENZOXAZEPIN COMPOUNDS SELECTIVE FOR PI3K P110 DELTA AND METHODS OF USE HOFFMANN LA ROCHE (CH) 2017-11-15 EP disclosed
US-9758522-B2 Hydrophobically tagged small molecules as inducers of protein degradation DANA-FARBER CANCER INSTITUTE, INC. (US) 2017-09-12 US disclosed
EP-3087058-B1 PROCESS FOR THE REGIOSELECTIVE SYNTHESIS OF PYRAZOLES ISAGRO SPA (IT) 2017-09-06 EP disclosed
US-20070142380-A1 Viral Polymerase Inhibitors BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2007-06-21 US disclosed
US-7223785-B2 Viral polymerase inhibitors BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2007-05-29 US disclosed
US-6600071-B2 Starting materials or intermediates and the cyclization of these under suitable reaction conditions to give compounds of the formula I. The intermediates of the formula II are novel. for argrochemicals BASF AKTIENGESELLSCHAFT (DE) 2003-07-29 US disclosed
US-20030109717-A1 Preparation of substituted hydroxypyrazoles GOTZ NORBERT (DE) 2003-06-12 US disclosed
US-6472538-B1 HIGH YIELD COUPLING, HYDROGENATION AND CYCLIZATION TO FORM CHEMICAL INTERMEDIATES FOR HERBICIDES BASF AKTIENGESELLSCHAFT (DE) 2002-10-29 US disclosed
EP-1127050-A1 METHOD FOR PRODUCING 1-SUBSTITUTED 5-HYDROXYPYRAZOLES BASF AKTIENGESELLSCHAFT (DE) 2001-08-29 EP disclosed
WO-2000027821-A1 METHOD FOR PRODUCING 1-SUBSTITUTED 5-HYDROXYPYRAZOLES BASF AKTIENGESELLSCHAFT (DE) 2000-05-18 WO disclosed
US-5948780-A ADMINISTERING A METALLOPROTEINASE INHIBITOR WARNER-LAMBERT COMPANY (US) 1999-09-07 US disclosed
US-5672615-A MATRIX-DEGRADING METALLOPROTEINASE INHIBITORS NOVARTIS CORPORATION (US) 1997-09-30 US disclosed
US-3965174-A HYDROGENATION CATALYST UNIROYAL, INC. (US) 1976-06-22 US disclosed